NAVB - Retracement - MA Retest Coming Up

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.

SHORT INTEREST
669.36K 09/13/19

P/E Current
-0.36

P/E Ratio (with extraordinary items)
-0.62

Average Recommendation: BUY

Average Target Price: 2.00